Gene · 5281
Papers2,279
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,279
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| B cells in head and neck squamous cell carcinoma: current opinion and novel therapy. | Cancer Cell Int | 2024 | 38245714 | PubTator, text mining | PubMed |
| Investigation of genetic determinants of cognitive change in later life. | Transl Psychiatry | 2024 | 38238328 | PubTator, text mining | PubMed |
| Maternal serum angiopoietins levels in pre-eclampsia and pregnancy outcomes. | Health Sci Rep | 2024 | 38226360 | PubTator, text mining | PubMed |
| Protein cargo in extracellular vesicles as the key mediator in the progression of cancer. | Cell Commun Signal | 2024 | 38200509 | PubTator, text mining | PubMed |
Exploratory Biomarker Analysis Using Plasma Angiogenesis-Related Factors and Cell-Free DNA in the TRUSTY Study: A Randomized, Phase II/III Study of Trifluridine/Tipiracil Plus Bevacizumab as Second-Line Treatment for Metastatic Colorectal Cancer. | Target Oncol | 2024 | 38194163 | PubTator, text mining | PubMed |
| Topical Application of Cell-Penetrating Peptide Modified Anti-VEGF Drug Alleviated Choroidal Neovascularization in Mice. | Int J Nanomedicine | 2024 | 38187905 | PubTator, text mining | PubMed |
| Angiogenic growth factors, oxidative stress and haematobiochemical measures as predictors of preeclampsia with and without foetal growth restriction: A case-control study in a Ghanaian population. | Placenta | 2024 | 38134545 | PubTator, text mining | PubMed |
| Targeting Senescent Cells as Therapy for CKD. | Kidney360 | 2024 | 38049936 | PubTator, text mining | PubMed |
| Structure of methyltransferase RedM that forms the dimethylpyrrolinium of the bisindole reductasporine. | J Biol Chem | 2024 | 38042494 | PubTator, text mining | PubMed |
| sFlt-1/PIGF ratio positive associated with non-dipper type change in ambulatory blood pressure monitoring(ABPM) for preeclampsia development. | Hypertens Res | 2024 | 38017185 | PubTator, text mining | PubMed |
| Elucidating the dynamics of polypeptide hormones in the physiological and preeclampsic placental trophoblast cells across gestation at single-cell level. | Life Med | 2023 | 39872304 | PubTator, text mining | PubMed |
| Tumor-Associated Macrophage Targeting of Nanomedicines in Cancer Therapy. | Pharmaceutics | 2023 | 38258072 | PubTator, text mining | PubMed |
| Systemic Oxidative Stress in Severe Early-Onset Fetal Growth Restriction Associates with Concomitant Pre-Eclampsia, Not with Severity of Fetal Growth Restriction. | Antioxidants (Basel) | 2023 | 38247471 | PubTator, text mining | PubMed |
| Current implications and challenges of artificial intelligence technologies in therapeutic intervention of colorectal cancer. | Explor Target Antitumor Ther | 2023 | 38213536 | PubTator, text mining | PubMed |
| Matrix Metalloproteinases and Their Inhibitors as Potential Prognostic Biomarkers in Head and Neck Cancer after Radiotherapy. | Int J Mol Sci | 2023 | 38203696 | PubTator, text mining | PubMed |
| Vascular Endothelial Growth Factor A VEGFA Inhibition: An Effective Treatment Strategy for Psoriasis. | Int J Mol Sci | 2023 | 38203230 | PubTator, text mining | PubMed |
| Targeting vascular normalization: a promising strategy to improve immune-vascular crosstalk in cancer immunotherapy. | Front Immunol | 2023 | 38193080 | PubTator, text mining | PubMed |
| Urinary Nephrin Levels Among Pregnant Women With Preeclampsia in Lagos, Southwest Nigeria: An Analytical Cross-Sectional Study. | Cureus | 2023 | 38152794 | PubTator, text mining | PubMed |
| Immune System, Inflammation and Autoantigens in Wet Age-Related Macular Degeneration: Pathological Significance and Therapeutic Importance. | Life (Basel) | 2023 | 38137838 | PubTator, text mining | PubMed |
| New Enhancing MRI Lesions Associate with IL-17, Neutrophil Degranulation and Integrin Microparticles: Multi-Omics Combined with Frequent MRI in Multiple Sclerosis. | Biomedicines | 2023 | 38137391 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5281/papers?page=5